Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Pruritus
ADR ID BADD_A03601
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.12      Pruritus NEC
23.03.12.001      Pruritus
Description A disorder characterized by an intense itching sensation. [CTCAE] An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief. [MeSH]
MedDRA Code 10037087
MeSH ID D011537
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Extremities itchy sensation of | General pruritus | Generalised itching | Generalized pruritus | Itch | Itch burning | Itching | Itching - generalised | Itching all over | Itching both hands | Itchy | Itchy legs | Itchy scalp | Itchy skin | Other specified pruritic conditions | Pruritis | Pruritus | Pruritus and related conditions | Pruritus cutaneous | Pruritus facial | Pruritus generalized | Pruritus NOS | Pruritus of both hands | Unspecified pruritic disorder | Pruritus aggravated | Pruritus breast | Hairy skin itching | Pruritus generalised | Localised itching | Localized itching | Generalized itching | Generalised pruritus | Itchy upper limbs | Periorbital pruritus | Localised pruritus | Localized pruritus | Itchy feet | Chronic pruritus of unknown origin | Pruritus sine materia | Nocturnal pruritus
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00250Benzylpenicilloyl g--
BADD_D00251Benzylpenicilloyl polylysine--
BADD_D00252Bepotastine--
BADD_D00253Bepotastine besilate--
BADD_D00258Betahistine--
BADD_D00260Betamethasone0.000557%
BADD_D00261Betamethasone dipropionate--
BADD_D00262Betamethasone valerate--
BADD_D00263Betaxolol--
BADD_D00264Betaxolol hydrochloride--
BADD_D00267Betiatide--
BADD_D00269Bexarotene0.000358%
BADD_D00270Bezafibrate--
BADD_D00271Bicalutamide--
BADD_D00274Bimatoprost0.009738%
BADD_D00277Bisoprolol--
BADD_D00278Bisoprolol fumarate--
BADD_D00280Bleomycin--
BADD_D00281Bleomycin sulfate--
BADD_D00283Boceprevir--
BADD_D00284Bortezomib--
BADD_D00285Bosentan--
BADD_D00286Bosutinib0.007040%
BADD_D00287Bosutinib monohydrate--
BADD_D00288Botric acid--
BADD_D00290Botulinum toxin type a--
BADD_D00291Brentuximab vedotin--
BADD_D00294Brimonidine0.003649%
BADD_D00296Brinzolamide--
BADD_D00299Bromazepam--
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 53 Pages